Aftab Dana
- SEC CIK
- 0001959132
In the past year, 4 open-market sale filings worth $7.70M and no purchases.
Current role at each company
- EXEL Exelixis, Inc.EVP, Research and Developmentas of May 28, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $7.70M
- 4 filings
- Net
- −$7.70M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Aftab Dana as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 28, 2026 (view filing) | May 26 | 2 days | Aftab DanaEVP, Research and Development | SSale | −43.5K | $50.35 | −$2.19M | −6.8%594.7K after | |
| Feb 26, 2026 (view filing) | Feb 24 | 2 days | Aftab DanaEVP, Research and Development | SSale | −47.9K | $44.50 | −$2.13M | −7.2%616.1K after | |
| Feb 23, 2026 (view filing) | Feb 19 | 4 days | Aftab DanaEVP, Research and Development | SSale | −29.9K | $44.35 | −$1.32M | −4.3%664.0K after | |
| Nov 13, 2025 (view filing) | Nov 11 | 2 days | Aftab DanaEVP, Research and Development | SSale | −48.4K | $42.50 | −$2.06M | −6.8%664.8K after | |
| May 5, 2025 (view filing) | May 1 | 4 days | Aftab DanaCSO/EVP Disc & Trans Research | SSale | −1.51K | $39.00 | −$58.8K | −0.2%693.2K after | 10b5-1 |
| Feb 26, 2025 (view filing) | Feb 24 | 2 days | Aftab DanaCSO/EVP Disc & Trans Research | SSale | −27.0K | $36.75 | −$991.8K | −5.0%511.9K after | |
| Nov 7, 2024 (view filing) | Nov 5 | 2 days | Aftab DanaCSO/EVP Disc & Trans Research | SSale | −97.0K | $35.00 | −$3.39M | −16.3%498.9K after | 10b5-1 |
| Nov 1, 2024 (view filing) | Oct 30 | 2 days | Aftab DanaCSO/EVP Disc & Trans Research | SSale | −1.16K | $31.40 | −$36.5K | −0.2%498.9K after | 10b5-1 |
| Aug 14, 2024 (view filing) | Aug 12 | 2 days | Aftab DanaCSO/EVP Disc & Trans Research | SSale | −20.9K | $27.06 | −$565.1K | −4.0%500.1K after | |
| Aug 9, 2024 (view filing) | Aug 7 | 2 days | Aftab DanaCSO/EVP Disc & Trans Research | SSale | −95.0K | $25.00 | −$2.38M | −15.4%521.0K after | 10b5-1 |
| Sep 1, 2023 (view filing) | Aug 30 | 2 days | Aftab DanaCSO/EVP Disc & Trans Research | SSale | −4.60K | $22.47 | −$103.4K | −1.1%399.9K after | 10b5-1 |
| Mar 1, 2023 (view filing) | Feb 27-28 | 2 days | Aftab DanaCSO/EVP Disc & Trans Research | SSale | −82.5K | $17.50 | −$1.44M | −19.0%351.5K after | 2 lots |